1. Home
  2. OZKAP vs BBIO Comparison

OZKAP vs BBIO Comparison

Compare OZKAP & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank OZK 4.625% Series A Non-Cumulative Perpetual Preferred Stock

OZKAP

Bank OZK 4.625% Series A Non-Cumulative Perpetual Preferred Stock

HOLD

Current Price

$16.36

Market Cap

0.0

Sector

Finance

ML Signal

HOLD

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

HOLD

Current Price

$74.97

Market Cap

14.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OZKAP
BBIO
Founded
N/A
2015
Country
United States
United States
Employees
3246
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
14.4B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
OZKAP
BBIO
Price
$16.36
$74.97
Analyst Decision
Strong Buy
Analyst Count
0
20
Target Price
N/A
$75.75
AVG Volume (30 Days)
N/A
2.0M
Earning Date
N/A
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$353,780,000.00
Revenue This Year
N/A
$128.44
Revenue Next Year
N/A
$76.14
P/E Ratio
N/A
N/A
Revenue Growth
N/A
62.46
52 Week Low
N/A
$25.34
52 Week High
N/A
$75.24

Technical Indicators

Market Signals
Indicator
OZKAP
BBIO
Relative Strength Index (RSI) 38.12 68.19
Support Level $16.28 $70.35
Resistance Level $16.65 $75.10
Average True Range (ATR) 0.23 2.33
MACD 0.02 -0.13
Stochastic Oscillator 16.06 98.77

Price Performance

Historical Comparison
OZKAP
BBIO

About OZKAP Bank OZK 4.625% Series A Non-Cumulative Perpetual Preferred Stock

Bank OZK is a bank holding company that owns and operates a community bank, Bank of the Ozarks. The bank operates offices in Arkansas, Georgia, Florida, North Carolina, Texas, California, New York and Mississippi. It provides a range of banking services which include deposit services such as checking, savings, money market, time deposit, and individual retirement accounts to loan services like real estate, consumer, commercial, and industrial loans. Apart from providing traditional banking products and services it also provides treasury management, trust and wealth management, financial planning, online banking, and other related services.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: